Sang Mi Lee
Sang Mi Lee is an experienced healthcare leader, pharmacist, and Executive Director at MORSE Consulting. With a global Executive MBA in Healthcare and Life Sciences and over 20 years of expertise spanning public healthcare, the pharmaceutical industry, consulting, not-for-profit, and front-line healthcare delivery, she specializes in market access, health technology assessment (HTA), pricing strategies, and reimbursement policy.
As Executive Director at MORSE Consulting, Sang Mi leads the firm’s strategic initiatives and helps clients navigate the complex Canadian reimbursement landscape. For her pharmaceutical and biotech clients, she helps to develop evidence-based market access strategies, optimize payer negotiations, and ensure sustainable healthcare solutions that benefit both patients and healthcare systems.
She was the first Senior Pharmacist at the pan-Canadian Pharmaceutical Alliance (pCPA) Office, becoming its Head in 2019 and reporting to the Governing Council of Assistant Deputy Ministers (ADMs). During her five-year tenure at the Office, the pCPA completed over 300 negotiations and conducted its strategic revitalization review. Sang Mi led negotiations for a broad spectrum of products (including immunotherapies, rare diseases, cell & gene therapies and more), successfully executing a variety of agreements, including complex and innovative agreements.
Before pCPA, Sang Mi worked for Ontario Public Drug Programs for over a decade, with experience managing Exceptional Access Program and Inherited Metabolic Diseases Program. She also played key roles in policy development, digital transformation, and designing new business processes in collaboration with internal and external I&IT consultants. She also has worked as a retail and drug information pharmacist.
Sang Mi joined MORSE from Hoffmann-La-Roche, where she held the role of Access Lead in Personalized Healthcare and Precision Oncology (therapeutics and diagnostics). She worked with cross functional teams in Canada and across the world, gaining experience in real-world evidence planning, HTA submissions, building innovative partnerships across health systems and with patients, and developing launch plans.
Sang Mi can be reached at SangMi@MorseConsulting.ca or (416)-270-6323.
